Market News

Orleans Capital Management Decreased Its Position in Gilead Sciences Com (GILD) by $361,390 as Market Valuation Rose; Sempra Energy Com (SRE) Shares Rose While Canada Pension Plan Investment Board Cut Its Position

Sempra Energy (NYSE:SRE) Logo

Orleans Capital Management Corp decreased its stake in Gilead Sciences Inc Com (GILD) by 29.91% based on its latest 2017Q4 regulatory filing with the SEC. Orleans Capital Management Corp sold 5,090 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 11,927 shares of the health care company at the end of 2017Q4, valued at $854,000, down from 17,017 at the end of the previous reported quarter. Orleans Capital Management Corp who had been investing in Gilead Sciences Inc Com for a number of months, seems to be less bullish one the $95.13B market cap company. The stock decreased 0.40% or $0.29 during the last trading session, reaching $72.96. About 1.81 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 26, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Canada Pension Plan Investment Board decreased its stake in Sempra Energy Com (SRE) by 87.53% based on its latest 2017Q4 regulatory filing with the SEC. Canada Pension Plan Investment Board sold 353,079 shares as the company’s stock rose 2.65% while stock markets declined. The institutional investor held 50,297 shares of the natural gas distribution company at the end of 2017Q4, valued at $5.38 million, down from 403,376 at the end of the previous reported quarter. Canada Pension Plan Investment Board who had been investing in Sempra Energy Com for a number of months, seems to be less bullish one the $28.95B market cap company. The stock increased 0.36% or $0.39 during the last trading session, reaching $109.7. About 302,741 shares traded. Sempra Energy (NYSE:SRE) has declined 0.38% since April 26, 2017 and is downtrending. It has underperformed by 11.93% the S&P500.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1 after the close. They expect $1.59 earnings per share, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.07 billion for 11.47 P/E if the $1.59 EPS becomes a reality. After $1.60 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Orleans Capital Management Corp, which manages about $1.29B and $140.45M US Long portfolio, upped its stake in J P Morgan Chase & Co Com (NYSE:JPM) by 12,395 shares to 14,596 shares, valued at $1.56M in 2017Q4, according to the filing. It also increased its holding in Bankamerica Corp (NYSE:BAC) by 59,115 shares in the quarter, for a total of 91,640 shares, and has risen its stake in Texas Instruments (NASDAQ:TXN).

Since January 2, 2018, it had 0 insider purchases, and 19 insider sales for $40.38 million activity. Cogan John Francis sold $437,588 worth of stock or 5,833 shares. $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by WILSON GAYLE E. 30,000 shares were sold by Alton Gregg H, worth $2.37 million on Thursday, January 11. $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Washington Robin L on Wednesday, February 21. Another trade for 100,000 shares valued at $8.02M was made by Meyers James R on Tuesday, January 16.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Wednesday, October 4 by Bank of America. The stock has “Buy” rating by Cowen & Co on Tuesday, May 30. The stock has “Buy” rating by Mizuho on Tuesday, July 25. BMO Capital Markets maintained it with “Hold” rating and $8200 target in Thursday, July 27 report. The company was maintained on Monday, February 5 by Mizuho. The rating was initiated by William Blair on Thursday, August 31 with “Buy”. On Wednesday, February 7 the stock rating was maintained by Cowen & Co with “Buy”. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, October 18. Cowen & Co has “Buy” rating and $90.0 target. On Thursday, February 22 the stock rating was maintained by Leerink Swann with “Hold”. The rating was initiated by Mizuho on Tuesday, November 8 with “Buy”.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It dropped, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. 2.77M were accumulated by Bb Biotech Ag. 75,000 are owned by Healthcare Value Capital Ltd Co. Jlb & Associates Inc invested in 119,676 shares. Kistler accumulated 9,188 shares. Letko Brosseau And Associates invested in 1.38 million shares. 4,020 are owned by Savings Bank Pictet And Cie (Asia) Limited. 130,570 were accumulated by Robecosam Ag. Moreover, Oregon Employees Retirement Fund has 0.96% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Glenmede Trust Company Na holds 647,257 shares. Pekin Singer Strauss Asset Il, a Illinois-based fund reported 13,738 shares. 3,503 were accumulated by Hilltop. S&Co Incorporated owns 0.05% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 5,809 shares. Thrivent Financial For Lutherans holds 53,355 shares. Professional Advisory invested 0.12% in Gilead Sciences, Inc. (NASDAQ:GILD). State Teachers Retirement Sys reported 2.29 million shares.

Investors sentiment increased to 1.27 in Q4 2017. Its up 0.08, from 1.19 in 2017Q3. It improved, as 34 investors sold SRE shares while 165 reduced holdings. 67 funds opened positions while 185 raised stakes. 192.21 million shares or 2.89% less from 197.93 million shares in 2017Q3 were reported. Brookmont Mgmt owns 3,341 shares or 0.15% of their US portfolio. Wells Fargo & Communications Mn owns 658,461 shares for 0.02% of their portfolio. Dowling & Yahnke Lc has invested 0.33% in Sempra Energy (NYSE:SRE). Neumann Management Ltd Liability Corporation has invested 0.15% in Sempra Energy (NYSE:SRE). 9,597 are held by Da Davidson &. Meag Munich Ergo Kapitalanlagegesellschaft Mbh has 12,024 shares for 0.05% of their portfolio. Reilly Financial Advsr Limited Liability reported 0.15% stake. Manufacturers Life Insurance Company The stated it has 0.03% of its portfolio in Sempra Energy (NYSE:SRE). Rothschild Investment Corporation Il reported 0.03% of its portfolio in Sempra Energy (NYSE:SRE). Blackrock reported 20.63M shares or 0.1% of all its holdings. State Of New Jersey Common Pension Fund D invested in 120,000 shares. Canada Pension Plan Investment Board owns 50,297 shares or 0.01% of their US portfolio. Schafer Cullen Capital owns 0.04% invested in Sempra Energy (NYSE:SRE) for 32,835 shares. Allsquare Wealth Management Llc reported 300 shares. Ftb Advisors has invested 0% of its portfolio in Sempra Energy (NYSE:SRE).

Canada Pension Plan Investment Board, which manages about $53.19B US Long portfolio, upped its stake in Cvs Health Corp Com (NYSE:CVS) by 271,540 shares to 1.29 million shares, valued at $93.73M in 2017Q4, according to the filing. It also increased its holding in Exact Sciences Corp Com (NASDAQ:EXAS) by 12,700 shares in the quarter, for a total of 942,700 shares, and has risen its stake in Automatic Data Processing In Com (NASDAQ:ADP).

Among 10 analysts covering Sempra Energy (NYSE:SRE), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Sempra Energy had 22 analyst reports since September 15, 2015 according to SRatingsIntel. The rating was downgraded by Barclays Capital to “Equal-Weight” on Thursday, June 8. The firm earned “Outperform” rating on Monday, January 25 by RBC Capital Markets. The rating was maintained by Guggenheim with “Buy” on Sunday, April 22. The firm earned “Hold” rating on Friday, August 4 by BMO Capital Markets. The stock has “Hold” rating by BMO Capital Markets on Thursday, May 11. As per Wednesday, October 11, the company rating was upgraded by Goldman Sachs. RBC Capital Markets maintained Sempra Energy (NYSE:SRE) on Sunday, November 5 with “Buy” rating. The rating was maintained by Wells Fargo with “Buy” on Wednesday, January 3. JP Morgan maintained it with “Neutral” rating and $104 target in Tuesday, March 6 report. The stock of Sempra Energy (NYSE:SRE) has “Outperform” rating given on Wednesday, February 28 by Wells Fargo.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *